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PENILAIAN MEMBRAN AMNION MANUSIA SEBAGAI PERANCAH 
UNTUK KEJURUTERAAN TISU PERIODONTAL: KAJIAN IN-VITRO 
ABSTRAK 
Membran amnion manusia (HAM) mempunyai sifat-sifat biologi bersesuaian untuk 
penjanaan semula tisu periodontal seperti tindak balas imunogenik rendah, anti-fibrosis, 
anti-radang dan kaya dengan komponen matriks luar sel. Kajian ini bertujuan untuk menilai 
keupayaan membran ini sebagai perancah untuk pertumbuhan sel utama dalam tisu 
periodontal, iaitu sel fibroblas ligamen periodontal manusia (HPDLFs).  
HPDLFs yang diperolehi secara komersial (Lonza, USA) telah dikulturkan di atas 
HAM yang diawet gliserol (USM Tissue Bank, Malaysia). Pelekatan dan morfologi 
permukaan HPDLFs telah dilihat melalui analisa histologi dan mikroskop imbasan elektron 
(SEM) masing-masing. Manakala kadar pembiakan sel pada hari 1, 3, 7, 14 dan 21 dinilai 
dengan menggunakan ujian alamarBlue® dan pelabelan nuklear DNA menggunakan 6-
diamidino-2-phenylindole (DAPI). 
Hasil penelitian histologi, menunjukkan HPDLFs membiak dari satu lapisan sel 
kepada beberapa lapisan sel pada membran amnion dari hari pertama hingga ke-7. Pada 
hari 14 dan 21, lapisan sel HPDLFs telah dikurangkan kepada lapisan sel tunggal dengan 
penampilan yang lebih leper dan sel-sel berbentuk gelendong yang lebih panjang. Analisa 
SEM menunjukkan pelekatan HPDLFs telah berlaku dengan baik pada membran amnion 
dari hari pertama hingga ke-3 dan seterusnya berlaku pertindihan pada hari ke-7. Dalam 
tempoh tersebut sel mengekalkan bentuk leper mereka. Namun, pada hari ke-14 dan 21, 
sel-sel telah menunjukkan perubahan pada morfologi dan kemudian bertukar menjadi 
bentuk bulat. Berdasarkan analisa statistik (Friedman’s Two-Way Analysis of Variance 
xiv 
 
oleh Ranks diikuti dengan perbandingan cara berpasangan) menggunakan SPSS 22.0, ujian 
pembiakan menunjukkan kebolehan sel membiak pada membran amnion telah meningkat 
dengan ketara dari hari pertama hingga ke-7 (p=0.002). Tetapi, kadar pembiakan sel 
menunjukkan pengurangan yang ketara pada hari 14 (p=0.002) dan hari 21 (p=0.005). 
Pewarnaan DAPI pada nuklear DNA telah menunjukkan kehadiran HPDLFs hingga hari 
ke-7 sahaja. 
Keputusan kajian ini menunjukkan bahawa membran amnion mampu berfungsi 
dengan baik sebagai perancah untuk HPDLFs dalam tempoh 7 hari. Kerencatan 
pertumbuhan sel kemudiannya mungkin disebabkan oleh beberapa perkara seperti 
penyekatan persandaran ketumpatan pertumbuhan atau pelepasan matrix 
metalloproteinase oleh HPDLFs yang mungkin telah mendegradasikan membran. 
Kesimpulannya, penemuan ini mencadangkan bahawa membran amnion manusia 
mempunyai potensi sebagai perancah untuk penjanaan semula tisu periodontal. Walau 
bagaimanapun, perilaku sel yang berhubungkait dengan membran dalam kultur untuk 
tempoh yang lebih lama memerlukan penelitian lanjut. 
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EVALUATION OF HUMAN AMNIOTIC MEMBRANE AS A SCAFFOLD 
FOR PERIODONTAL TISSUE ENGINEERING: AN IN VITRO STUDY 
 
ABSTRACT 
 
Human amniotic membrane (HAM) has many biological properties suitable for 
periodontal tissue regeneration such as low immunogenicity, anti-fibrosis, anti-
inflammation and rich in extracellular matrix component. This study aimed to evaluate the 
ability of this membrane as a scaffold for the growth of the predominant cells in periodontal 
tissues, human periodontal ligament fibroblasts (HPDLFs).  
Commercially available HPDLFs (Lonza, USA) were seeded on glycerol preserved 
HAM (USM Tissue Bank, Malaysia). HPDLFs attachment and surface morphology were 
observed through histological analysis and scanning electron microscopy (SEM) 
respectively. While the cell proliferation was assessed using alamarBlue® proliferation 
assay and nuclear labeling of DNA using 6-diamidino-2-phenylindole (DAPI) at day 1, 3, 
7, 14 and 21. 
Histologically, HPDLFs showed mono layer to multilayers attachment on HAM 
from day 1 to day 7. On day 14 and 21, HPDLFs cell layers were reduced to single cell 
layer with more flattened appearance and longer spindle shaped cells. SEM analysis 
demonstrated that HPDLFs had attached appropriately on HAM surface at day 1 to day 3 
and became overlapping at day 7, while maintaining their flat shape. However, by day 14 
and 21 the cells demonstrated alteration in their morphology and later became rounded in 
shape. Based on statistical analysis (Friedman’s Two-Way Analysis of Variance by Ranks 
xvi 
 
followed by pairwise comparison) using SPSS 22.0 proliferation assay showed that 
HPDLFs viability on HAM had increased significantly from day 1 to day 7 (p=0.012). 
However, the proliferation of cells showed significant reduction at day 14 (p=0.002) and 
day 21 (p=0.005). DAPI staining of nuclear DNA showed the presence of HPDLFs up to 
day 7 only. 
This study showed that HAM is able to function well as a scaffold for HPDLFs 
within 7 days. Retardation of cellular growth after 7 days could be due to possible reasons 
such as density dependent inhibition of growth or the release of matrix metalloproteinases 
by the HPDLFs that might have degraded the membrane.  
In conclusion, the findings suggest that HAM could be a promising scaffold for 
periodontal regeneration. However, cells’ behaviour in relation to the membrane over 
longer culture duration requires further investigations. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background of study 
Periodontitis is the 6th most prevalent health condition in the world  (Kassebaum et 
al., 2014). It is a microbial-induced inflammatory condition of the periodontium resulting 
in the loss of the structures supporting and surrounding the tooth. These structures include 
alveolar bone, cementum, periodontal ligament and gingiva. If the condition is left 
untreated eventually, it will lead to tooth loss (Han et al., 2014). To halt the on-going 
disease process, nonsurgical periodontal therapy such as scaling and root planing are 
carried out to disrupt bacterial biofilm and limit the disease progression. Although, these 
conventional therapies may avert the disease process, they are unlikely able to restore or 
rebuild the affected complex tri-phasic interphase of cementum, bone and periodontal 
ligament.  
The main goal of periodontal therapy has always been to regenerate the loss of the 
diseased periodontal structures, to maintain its form and function (Nakahara, 2006). To 
achieve this goal, regenerative approaches including guided tissue regeneration (GTR) 
with membrane and/ bone graft placement, use of growth factors, and enamel matrix 
derivatives (EMD) (Esposito et al., 2009) have been introduced. However, the results of 
these approaches are frequently associated with uncertain or poor clinical predictability 
(Esposito et al., 2009; Chen et al., 2010). Therefore, new strategies are needed to overcome 
the challenges.  
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In 1993, Langer and Vacanti had proposed tissue engineering as a promising 
alternative for restoring or reconstructing lost tissue (Langer and Vacanti, 1993). Tissue 
engineering aims to restore, regenerate or improve the defective or damaged tissues due to 
various disease conditions. It uses the principle of de novo ‘engineering’ of tissue 
constructs either ex vivo (extra corporeally) or in situ (intra corporeally). The engineering 
process utilizes the regenerative capacity of stem cells and their proliferation/ 
differentiation within a three-dimensional (3D) framework (scaffold) (Semenov, 2011). 
Since then, the concepts of tissue engineering, stem cell research, gene therapy and 
therapeutic cloning have vastly revolutionized the modern therapeutics (Koh and Atala, 
2004; Rodriguez-Vazquez et al., 2015). Presently, these modern concepts and principles 
are applied in regenerative dentistry to regenerate the periodontal structures.  
Tissue engineering involves the use of desired regenerative cells that are cultured 
in laboratories over a substrate as two-dimensional (2D) cell sheet or three-dimensional 
(3D) structure and then transferred to the defect site to enhance the regenerative process. 
Apart from cellular strategies in periodontal regeneration, the use of bioactive scaffolds 
(Shimauchi et al., 2013) alone for mechanical support or as carrier for regenerative cells 
with or without growth factors are also being used. The recent advancements in the scaffold 
design and biomaterials have enhanced the present capabilities of scaffolds to recapitulate 
the natural extracellular matrix (ECM) function both temporally and spatially. Many 
natural, synthetic, semi synthetic and hybrid scaffolds have been constructed and applied 
for tissue regeneration (Causa et al., 2007). 
Amniotic membrane is a well reputed natural biomaterial and  has been in use for 
various medical procedures for over a century (Niknejad et al., 2008). It is the inner most 
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layer of the fetal membrane and completely enfolds the embryo, demarcating the amniotic 
cavity. The reasons for its diverse applications apart from being easily available and cheap 
is, its exceptional biological properties. These include anti-inflammatory, anti-scarring, 
anti-microbial (Chopra & Thomas, 2013), anti-angiogenic, promoter of epithelialization 
(Mamede et al., 2012), and anti-carcinogenic properties (Niknejad et al., 2014). Over the 
past few decades, with the advancements in tissue engineering, biomaterial sciences and 
scaffold designs, this ‘miracle’ membrane was introduced into periodontal tissue 
engineering (Litwiniuk and Grzela, 2014).  
Adachi et al. (2014a; 2014b) demonstrated that periodontal cells cultured on human 
amniotic membrane (HAM) substrate express essential proteins for cell-substrate adhesion 
and maintaining tissue integrity. HAM also showed good adhesion with periosteal-derived 
cell sheet (Amemiya et al., 2014) and dental pulp-derived cell sheet (Honjo et al., 2014). 
Iwasaki et al. (2014) used rat periodontal model (by surgically creating periodontal defects 
into first maxillary molars of rats) and transplanted periodontal ligament stem cells 
(PDLSC)-amnion into these sites showing enhanced periodontal regeneration. 
 Despite the advances in tissue engineering, the ideal scaffold that is cheaper, easily 
available and has all the biophysical and biochemical properties necessary for periodontal 
reconstruction is yet to be established. With the best of our knowledge, lack of data 
available on the efficacy of HAM as a scaffold for periodontal ligament fibroblast culture. 
Therefore, in this study we have evaluated the efficacy of this membrane as a scaffold for 
human periodontal ligament fibroblasts (HPDLFs) for future use in periodontal tissue 
engineering.  
 4 
 
1.2 Justification of study 
In order to regenerate periodontium we need a good biocompatible scaffold that 
would integrate and support the growth of regenerative cells while providing mechanical 
strength. Stem cell based-periodontal tissue regeneration is becoming extensively studied 
domain due to its remarkable results in pre-clinical studies (Iwasaki et al., 2014; Wu et al., 
2016). This technique can be expensive and time consuming as it requires laboratory 
procedures and expensive scaffolds.  
In the past few years much advancement has been made to search for the ideal 
scaffold which, among many benefits, should be cost effective and easily available. On this 
advantage, amniotic membrane is being investigated. Its ability to harness the cells of 
regenerative capacity has been established in a study by Adachi et al. (2014). In another 
study, its regenerative capability as a scaffold in rat periodontal models has also been 
demonstrated (Iwasaki et al., 2014). However, none have investigated the ability of HAM 
to attach and proliferate the periodontal fibroblasts, which are the predominant cells of 
periodontal tissue and play key role in its repair and regeneration. 
This research will help us get one step closer to our goal of clinical transition by 
providing an alternate source of scaffolds which will be locally procured and processed, 
and introduce amniotic membrane in periodontal clinical practices. With the best of our 
knowledge, there are very limited data available on the use of HAM as scaffolds for 
HPDLFs. 
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1.3 Objectives of the study  
1.3.1 General objective 
To evaluate the efficacy of human amniotic membrane as a scaffold for human 
periodontal ligament fibroblasts cell growth. 
1.3.2 Specific objectives 
i. To evaluate the attachment of cultured human periodontal ligament fibroblasts on 
human amniotic membrane histologically by using hematoxylin and eosin staining. 
ii. To determine the proliferation rate of the cultured human periodontal ligament 
fibroblasts on human amniotic membrane using alamarBlue® proliferation assay. 
iii. To evaluate the surface morphology of the cultured human periodontal ligament 
fibroblasts on human amniotic membrane using scanning electron microscopy. 
1.4 Research question 
1. Is there any difference in the attachment and proliferation level of HPDLFs seeded 
on HAM on different observation days? 
1.5 Null hypothesis 
1. There is no difference in the attachment and proliferation level of HPDLFs seeded 
on HAM on different observation days. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Development of periodontium 
Through the understanding of the development and formation of periodontal tissues 
we can formulate mechanisms for repair and regeneration by retracing the footsteps of 
development (Bartold et al., 2000). 
During the first three weeks of embryonic development cells undergo rapid 
proliferation and migration. By about 8 days, cells are differentiated into two distinct 
layers: endoderm and ectoderm. By the third week, another layer is formed between the 
endoderm and ectoderm, that is, the mesoderm. In the next few weeks the ectoderm 
thickens to form raised margins called neural folds which later fuse to form the neural tube. 
The cells at the lateral borders or crest of this neuroectoderm dissociate from their 
neighbours to form the neural crest cells. Most of the dental structures originate from cells 
derived from these neural crest cells. These structures include dentine and cementum and 
the supporting structures of the tooth (periodontal ligament and the alveolar bone). On the 
other hand, the enamel is formed from the cells which originate from the ectoderm.  
The tooth development begins by the sixth week of embryogenesis starting from 
the thickening of the oral epithelium lining the future sites of dental arches to form dental 
lamina. Morphologically, the tooth development is divided into three stages, namely, bud, 
cap and bell stage (Figure 2.1). In the bud stage, the epithelial cell of dental lamina begins 
to invaginate into the underlying connective tissue. Continuous proliferation of epithelium 
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forms a parabolic or cap like structure. At this stage, enamel organ is at its earliest stage of 
development. Underneath the epithelial cap, the mesenchymal cells proliferate to form the 
dental papilla. The dental papilla will later on form the dentine and the dental pulp. The 
dental papilla continues to encapsulate the enamel organ to form the dental follicle from 
which the future root cementum, periodontal ligament and alveolar bone will develop. 
During the bell stage, the enamel organ continues to grow and form bell like structure with 
four types of cells.  The outer enamel epithelium forms the outer portion of enamel organ. 
The inner enamel epithelium lines the inner portion of enamel organ, which will eventually 
differentiate into ameloblasts and form enamel. Stratum intermedium lines the inner 
enamel epithelium, and stellate reticulum lies between stratrum intermedium and outer 
enamel epithelium. 
Once the bell stage is complete, crown formation begins. Odontoblasts deposit 
dentine and lay the foundation of matrix for the ameloblasts to differentiate into secretory 
cells and produce enamel matrix. After the enamel and dentine formation is nearly 
completed at future cementoenamel junction, the root formation begins.  
After crown development is complete, the outer and inner enamel epithelium form 
bilayer cell structure called Hertwig’s epithelial root sheath which separates the dental 
papilla from dental follicle. The cells of the inner enamel epithelium induce the adjacent 
cells of dental papilla to form odontoblasts which deposit root dentine. The Hertwig’s root 
sheath disintegrates into fragments, but never completely disappears and leaves behind 
remnants called epithelial cell rests of Malassez. After the disintegration of Hertwig’s root 
sheath, the dental follicle cells attach and align onto the matrix coating dentine surface. 
These dental follicle cells differentiate into cementoblasts and form the root cementum. 
  
  
Figure 2.1 Stages of tooth development, adopted from Bei (2009) 
8
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The cementum deposition occurs during tooth development and also after eruption 
during normal functions. Cementoblasts, cementocytes and fibroblasts deposit cementum, 
while cementoblasts are the primary source (Schroeder, 1992; Bosshardt and Schroeder, 
1996). These cells are located within the periodontal ligament and have their origin from 
dental follicle cells. Moreover, the mesenchymal cells in the periodontal ligament have the 
potential to differentiate into periodontal ligament fibroblasts and cementoblasts. 
The periodontal ligament is mainly produced by the fibroblasts. These periodontal 
ligament fibroblasts have their origin from dental follicle cells and differentiate during root 
development. As the root is being formed, the cementoblasts deposit cementum on the root 
surface, and the fibres of periodontal ligament fibroblasts (PDLFs) appear. The fibres are 
inserted into the cementum and the alveolar bone, and become mature as the tooth erupt.  
The alveolar bone (bone lining the tooth socket) is formed during root formation 
and is derived from cells called osteoblasts which have their origin in dental follicle. The 
gingival tissue is formed from both ectodermal origin, forming the superficial epithelium, 
and mesodermal origin, forming the underlying connective tissue. The non-keratinized 
junctional epithelium of gingiva has origins in enamel organ. Whereas, both the non-
keratinized sulcular epithelium and the keratinized gingival epithelium has oral mucosal 
origin (Bartold and Narayanan, 1998). 
2.2 Periodontal tissue and its biology 
Periodontium is the supporting structure of the tooth comprising gingiva and the 
attachment apparatus. The attachment apparatus is composed of alveolar bone, periodontal 
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ligament (PDL) and cementum (Newman, 2011) (Figure 2.2). It forms a biological and 
functional tissue which corresponds to age or environmental changes.  
The outer surface of periodontium is formed by the gingiva. It covers the alveolar 
bone and the tooth root just coronal to cementoenamel junction and acts as a barrier to 
mechanical and microbial damage. Anatomically, it is divided into marginal or unattached, 
attached and interdental papilla (Newman, 2011).  
A gingival sulcus is present in the form of shallow crevice or space surrounding the 
tooth on one side and the epithelial lining of the marginal gingiva on the other. Clinically 
this space can be measured using a metallic instrument called periodontal probe. In 
clinically normal gingiva, this probing depth is 1 to 3 mm (Highfield, 2009). This is one of 
the most important clinical parameters used to evaluate the periodontal status. 
Histologically, gingiva consists of gingival epithelium and the gingival connective 
tissue. The gingival epithelium is formed by continuous lining of stratified squamous 
epithelium. Morphologically and functionally, gingival epithelium is divided into three 
areas. The oral or outer epithelium, sulcular epithelium and the junctional epithelium. Apart 
from its function as a barrier, the gingival epithelium, also helps in selective interchange 
with oral environment.  
The gingival connective tissue is formed of collagen fibers (88.4%), fibroblasts 
(8.4%), blood and lymph vessels (7.3%), edema (4.9%) and residual tissues (unidentified 
cells and nerves) (2.7%) (Daniel and Dupont, 1980). The connective tissue has cellular and 
extracellular components composed of fibers and ground substance. While the ground 
substance is mainly composed of water, it also has proteoglycans (mainly hyaluronic acid 
chondroitin sulphate) (Bartold et al., 1983) and glycoproteins (mainly fibronectin) 
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(Romanos et al., 1993). Fibronectin helps fibroblasts to bind to the fibers (Klebe, 1974; 
Yamada et al., 1976; Yamada and Olden, 1978; Grinnell and Feld, 1979 ) and laminin, 
another glycoprotein, helps it to bind to epithelial cells (Terranova and Lyall, 1986; Pakkala 
et al., 2002). Laminin receptor on gingival epithelial cell surface also indicates its role in 
maintaining cemento-epithelial junction by interactions of cementum laminin and its 
receptor on gingival epithelium (Sengupta et al., 1991). 
Underneath the gingiva, the teeth are located within the alveolar bone (bony socket) 
of the alveolar processes of maxilla and mandible. The alveolar process consists of thin 
lamella of bone lining the tooth socket wall and containing inserting Sharpey’s fibers 
(Johnson, 1987) and the thicker outer layer of bone, lining the labial and lingual aspects of 
the alveolar process. The thick layer constitutes of cortical plates and spongy bone. 
The periodontal ligament (PDL) is present across the space between the root surface 
and the alveolar bone. It is a fibrous connective tissue and is produced mainly by fibroblasts 
(Lekic and McCulloch, 1996). It is highly cellular and vascular. It has increased collagen 
turnover, due to which it has high remodelling rate (Mensing et al., 2011). Presence of 
multipotent post-natal periodontal stem cells (PDLSCs) in PDL have also been 
demonstrated (Ivanovski et al., 2006). Cementum is a hard tissue covering the root surface 
(Denton, 1939). It provides anchorage to the periodontal ligament by insertion of Sharpey’s 
fibers and also protects the pulp by covering the porous dentine on the root surface (Short 
and Johnson, 1990).  
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Figure 2.2 (A) Healthy periodontium. (B) Diseased periodontium (gingivitis and 
periodontitis). 
(A) 
(B) 
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2.2.1 Human periodontal ligament fibroblast cells 
HPDLFs are the predominant cells in the periodontal tissues and are of 
mesenchymal origin. They are large spindle shaped or stellate cells with an oval nucleus 
(Nanci, 2013). They have an extensive cytoplasm with an abundance of organelles 
associated with the synthesis and secretion of protein. HPDLFs possess well- developed 
cytoskeleton with adherens and gap junctions (Nanci and Bosshardt, 2006). HPDLFs from 
young donors ages between 15-19 years were observed to be small, whereas HPDLFs from 
older donors ages 20-80 years showed diverse and large-spread out shapes (Sawa et al., 
2000). 
HPDLFs have a finite population doubling (PD) number of 7.1±2.9 (Sawa et al., 
2000).  Whereas, for human fibroblasts, the proliferative life span in vitro ranges from 30-
60 population doublings and it decreases with increase in donor age (Dimri et al., 1995). 
The periodontal cells in tissue proliferate at a daily rate of 0.5-2 percent, however, an 
increase in the proliferation of the fibroblast cells is seen during orthodontic forces and 
injury (Gould et al., 1980). 
HPDLFs play an important role in the development, function and regeneration of 
periodontal tissues (McCulloch, 1995). Fibroblasts synthesize collagen (Kumada and 
Zhang, 2010; Limeback et al., 2016), elastic fibers (Tsuruga et al., 2002; Sawada et al., 
2006), glycoproteins and glycosaminoglycans (Bartold and Page, 1985; Baglole et al., 
2013). Fibroblasts also produce cytokines by which they mediate tissue destruction and 
stimulate bone resorption by osteoclastic stimulation (Genco, 1992). Most extra cellular 
matrix components are mediated by the production of matrix metalloprotenases (MMPs) 
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and tissue inhibitor of matrix metalloproteinases (TIMPs) by these fibroblasts (Sorsa et al., 
2004; Verstappen and Hoff, 2016). Therefore, by the balance of these enzymes, the 
periodontal fibroblasts maintain the periodontal structures during physiological turn over. 
HPDLFs have cementoblast-like and/ or osteoblast-like properties and can form 
mineralized nodules in vitro. They also express bone-associated markers, form cementum-
like tissues and modulate osteoclastogenesis in vivo (Nohutcu et al., 1997; Flores et al., 
2008). Primary periodontal cell cultures at early passages maintain the rich phenotypic and 
functional heterogeneity of fibroblasts characteristic of the original tissue when compared 
to late passages (Goseki et al., 1996; Itaya et al., 2009). 
2.3 Classification of periodontal disease 
Periodontitis is the inflammatory condition of the periodontium induced by 
bacteria. As the disease progresses, it causes degenerative changes in the periodontium, 
resulting in the loss of periodontal ligament and alveolar bone. As a result, the gingival 
sulcus deepens and forms periodontal pocket (Chen et al., 2012). 
The 1999 classification of periodontal diseases enlisted, apart from the gingival 
diseases, seven major categories of destructive periodontal diseases (Armitage, 1999): 
• Chronic periodontitis 
• Aggressive periodontitis 
• Periodontitis as a manifestation of systemic diseases 
• Necrotizing periodontal disease 
• Abscesses of the periodontium 
• Combined periodontic-endodontic lesions 
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• Developmental or acquired deformities and conditions 
2.3.1 Pathogenesis of periodontal disease 
The dental biofilm/ bacterial plaque accumulation is considered to be the primary 
initiating agent in the aetiology of periodontal diseases. During the disease process, the 
periodontal tissues undergo several changes. During the initial 2-4 days of plaque 
accumulation, histologically low grade inflammation can be seen which is characterized 
by dilation of vascular network and increase in vascular permeability, this is known as 
initial lesion. However, there are no signs of clinical inflammation during this stage. 
Neutrophils and monocytes then migrate from the gingival vasculature to the site of the 
chemotactic stimuli, that is, the connective tissue near the gingival sulcus. Gingival 
crevicular fluid (GCF) also increases due to increases hydrostatic pressure in the local 
microcirculation. After one week of plaque accumulation the gingiva becomes slightly 
swollen due to edema and also erythematous due to capillary proliferation and vasodilation. 
This corresponds to the early clinical sign of gingivitis and hence called early lesion. The 
flow of gingival crevice fluid is increased along with notable collagen destruction. 
Polymorphonuclear cells (PMNs) migrate towards gingival sulcus and phagocytose 
bacteria (Miller et al., 1984; Scott and Krauss, 2012). Fibroblasts begin to show cytotoxic 
effects with decreased capacity for collagen formation.  
If the condition persists it becomes as established lesion which clinically correlates 
to moderate to severe chronic gingivitis. A predominance of plasma cells and B 
lymphocytes can be seen with an increase in immunoglobulin G1 (IgG1) and G3 (IgG3) 
subclasses (Okada et al., 1983). Blood flow is impaired, and the collagenolytic activity is 
increased. Neutrophils accumulate in the tissue and release their lysosomal contents to kill 
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bacteria which are still not phagocytose, causing further destruction. Neutrophils migrate 
towards the sulcus and release matrix metalloproteinases (MMP-8 and MMP-9), making 
the junctional and sulcular epithelium ulcerated. Hence, giving the common feature of 
chronic gingivitis of bleeding on probing.  
The final stage is demarcated by the transition from gingivitis to periodontitis 
known as the advanced lesion or phase of periodontal breakdown.  The bacterial plaque 
products differentiate bone progenitor cells into osteoclasts or act directly on osteoblasts 
and inhibit their actions and reduce their numbers. The host inflammatory cells release 
factors that play a role in periodontal destruction such as prostaglandins, including 
interlukin-1a (IL-1a) and IL-b, and tumor necrosis factor alpha (TNFa) (Page, 1991; 
Chiang et al., 1999). The junctional epithelium migrates apically and the pocket deepens. 
All these events leading up to the irreversible attachment loss and bone loss which can be 
observed histologically and clinically.  
2.3.2 Risk factors 
Any attribute, exposure or characteristic that can predispose an individual to disease 
or injury can be referred to as a risk factor (World Health Organization, 2014). Although 
the bacterial plaque is essential for the periodontal disease initiation, there are various 
factors which determine the severity of periodontal disease, its progression and response 
to therapy.  
The plaque-induced chronic periodontitis is a slowly progressing disease, however, 
when coupled with a systematic condition the rate of periodontal destruction is increased 
due to altered host responses. Diabetes and periodontal disease have two-way relationship, 
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in which diabetes increasing the risk for periodontitis and periodontal inflammation 
negatively affecting the glycaemic control (Nishimura et al., 2003; Preshaw et al., 2012). 
Some environmental and behaviour factors also affect the severity and extend of 
periodontal disease. While dietary habits, alcohol consumption, socioeconomical 
conditions and stress levels influence periodontal status, smoking is a major risk factor for 
bone loss, furcation involvement and deeper pockets (Albandar et al., 2000; Newman, 
2011). Several genetic risk factors for periodontitis have also been identified, such as IL-
1, TNF-α, Fcgamma receptor, CD14, TLR-2 and TLR-4 gene polymorphisms, which 
suggests genetic predisposition to periodontitis. (Loos et al., 2005; van Dyke and Dave, 
2005).  
2.4 Management of periodontal diseases 
2.4.1 Initial phase 
The initial periodontal therapy, also known as phase 1 periodontal therapy or non-
surgical periodontal therapy, aims to control the bacterial infection by completely 
removing plaque and calculus, which harbors the bacteria, correcting defective 
restorations, treating carious lesions, managing orthodontic tooth movements, treatment of 
food impaction areas and extracting hopeless teeth. Motivating the patient to maintain good 
oral hygiene practices by adhering to effective daily plaque removal at home is one specific 
aim of the initial therapy (Newman, 2011). In order to reduce plaque, mechanical and/ or 
chemical plaque reduction techniques can be adopted. Scaling and root debridement are 
done to mechanically remove the calculus deposits. The bacterial load can also be reduced 
chemotherapeutically using systemic antimicrobials (oral antibiotic) such as clindamycin, 
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amoxicillin/ clavulanate and metronidazole (Slots, 2002) or local antimicrobials which 
may be introduced directly into the periodontal pockets (Kinane, 2000; Nair and Anoop, 
2012). Kinane (2000) demonstrated the effectiveness of slow release devices: Actisite 
(tetracycline fiber), Dentomycin (minocycline) and Elyzol (metronidazole dental gel) 
adjunctively with root planing as compared to root planing alone. Although all three locally 
applied antimicrobial systems were effective, Actisite placement gave the greatest probing 
pocket depth reduction during six months after treatment. 
2.4.2 Corrective or surgical phase 
After the initial periodontal therapy phase, if the periodontal pocket or defect 
persists, more advanced therapy may be required to treat the condition. One such 
periodontal surgical therapy which is limited to the gingival tissues only without involving 
the osseous structures is called gingivectomy (Newman, 2011). It involves removing the 
pocket wall surgically and cleaning the area. Apart from the conventional gingivectomy 
using knifes and blades, now gingivectomy using LASERS (Light Amplification by 
Stimulated Emission of Radiation) are also being used (Shankar et al., 2013; Kumar et al., 
2015b). Moreover, periodontal flap surgeries may be undertaken to allow better visibility 
and access to bone and root surface. Flaps can also be displaced to treat various 
mucogingival related defects or for access to pocket depths and their reduction/ elimination 
(Newman, 2011).  
Moreover, depending on defect size and/ or tooth root exposure, bone graft 
materials are being used. These can be autografts (from same individual), allografts (from 
different individual from the same species), xenografts (from different species) or 
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alloplastic (non-biological material). Autografts can be from intraoral site or from extraoral 
sites such as iliac crest autografts. Allografts are usually available from tissue banks as 
undecalcified freeze-dried bone allograft or demineralized freeze-dried bone allograft.  
Alloplastic materials include hydroxyapatite-HA and tricalcium phosphate-TCP (Bansal et 
al., 2014; Gupta, 2014; Jain et al., 2014; Matsuura et al., 2015).  
2.5 Periodontal regeneration and tissue engineering   
The American Academy of Periodontology (1992) defines periodontal regeneration 
histologically as regeneration of the tooth’s supporting tissues, including alveolar bone, 
periodontal ligament and cementum over a diseased root surface. This has to be assessed 
not only through clinical parameters but also re-entry evaluations and histological analysis 
in animal models. 
Bartold et al. (2000)  mentioned that there are at least four criteria, based on the 
natural morphology of the dento-gingival complex, that determine periodontal 
regeneration: (a) A functional epithelial seal must be re-established, no more than 2 mm in 
length, at the most coronal portion of the tissues, (b) Both the periodontal ligament and the 
dentogingival fiber complex must be reproduced by the insertion of new connective tissue 
fibers (Sharpey’s fibers) into the previously exposed root surface, (c) New acellular, 
extrinsic fiber cementum must be reformed on the previously exposed root surface and (d) 
Alveolar bone height must be restored to within 2 mm of the cemento-enamel junction. To 
obtain such a degree of regeneration all the processes involved in periodontal 
reconstruction have to be strongly rooted in the biological stages of development. 
Therefore, a model of regeneration is adopted in tissue engineering, in which careful 
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selection of regenerative cells intermixed with a suitable extracellular matrix has to be 
constructed. 
Tissue engineering is a relatively new but rapidly progressing field which aims to 
develop procedures and biomaterials to support and facilitate the development of new 
tissues to replace lost/ damaged tissues, with great potential to fulfil the functional needs. 
Tissue engineering can be classified into passive and active tissue engineering based on the 
role of cells played in the regeneration of the structures. Passive tissue engineering consists 
of procedures like guided tissue regeneration (GTR) in which regenerative cells are not 
actively introduced into the defect rather a barrier membrane is placed to passively induce 
the innate regenerative cells to construct the structures. Whereas, in active tissue 
engineering growth factors and cell therapy plays an active role. Growth factors, such as 
enamel matrix derivatives (EMD) (Venezia et al., 2004; Esposito et al., 2009), platelet-rich 
plasma (PRP) (Rosello-Camps et al., 2015) or specific growth/ differentiation factors such 
as periodontal growth factor (PDGF), insulin like growth factor 1 (IGF-1), bone 
morphogenetic protein 2 (BMP-2) and 7 (BMP-7) are used to stimulate periodontal 
regeneration (Lynch et al., 1989; Kaigler et al., 2011; Nevins et al., 2013; Rao et al., 2013). 
2.5.1 Guided tissue regeneration 
Over the past few decades, guided tissue regeneration (GTR) has been established 
as an effective treatment modality for periodontal reconstruction (Needleman et al., 2002). 
The principle behind this technique is to prevent the epithelial migration along the cemental 
wall of pocket, which forms long junctional epithelium, by placing a barrier (membrane) 
to cover the bone and periodontal ligament. Initially nonresorbable membranes were used 
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but they required a second surgical procedure to remove them. Therefore, biodegradable 
membranes were introduced into this procedure. They were procured from different species 
such as bovine, porcine or cargile (from the peritoneum of the ox). Other membranes were 
derived from polylactic acid, Vicryl (polyglactin 910) and freeze dried dura mater. 
However, the results of these procedures were usually associated with poor clinical 
predictability and less effective in producing periodontal regeneration (Chen et al., 2010). 
2.5.2 Cell-based periodontal regeneration 
The recent advances in stem cell research has led to cell-based tissue engineering 
strategies for periodontal regeneration. These strategies include the use of regenerative 
cells integrated in a 3D scaffold or cultured on a substrate to form cell sheets and then 
transferred into the defect. 
 Cells that have been used for periodontal regeneration include: dental pulp stem 
cells (DPSCs) (Gronthos et al., 2000; Aimetti et al., 2014), periodontal ligament stem cells 
(PDLSCs) (Ding et al., 2010; Zhu and Liang, 2015), bone marrow mesenchymal stromal 
cells (BMMSCs) (Yang et al., 2010), alveolar periosteal cells (APCs) (Jiang et al., 2010), 
stem cells from apical papilla (SCAPs) (Sonoyama et al., 2008), and alveolar bone 
mesenchymal stem cells (MSCs) (Li et al., 2008; Lin et al., 2009). 
The use of cell based approaches have been shown to enhance periodontal 
regeneration in various in-vitro and in-vivo settings (Rios et al., 2011; Abbayya et al., 2015; 
Yan et al., 2015). However, it is still indistinct whether the transplantation of autologous 
cells differentiate into osteoblasts, cementoblasts, and fibroblasts to form bone, cementum, 
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and periodontal ligament, respectively or whether they engage the surrounding host cells 
to support and facilitate the regenerative process.  
In particular, PDL tissue contains multipotent stem cell populations and contributes 
to the regeneration of complex periodontal structures (Seo et al., 2004; Liu et al., 2008; 
Pejcic et al., 2013; Zhu and Liang, 2015). BMMSCs have been reported to differentiate 
into PDL, and the transplantation of BMMSCs has facilitated periodontal regeneration 
(Kawaguchi et al., 2004; Hasegawa et al., 2006; Yang et al., 2010). APCs have also been 
reported to improve periodontal regeneration (Yamamiya et al., 2008; Kawase et al., 2009; 
Jiang et al., 2010). Moreover, PDLSCs hold the potential to form bone, cementum and 
periodontal ligament-like structures and to enhance overall periodontal regeneration (Ding 
et al., 2010; Hynes et al., 2012). These cells are being used in combination with various 
natural and synthetic biomaterial scaffolds along with required growth factors to regenerate 
periodontal tissues. But the ideal combination of cells, scaffolds and growth factors is yet 
to be established. 
2.6 Challenges of periodontal regeneration and the pivotal role of scaffolds 
Scaffolds are three-dimensional (3D) porous solid biomaterials that mimic the 
natural extracellular matrix (ECM) (Dhandayuthapani et al., 2011). They are designed to 
perform some or all of the following functions (Langer and Tirrell, 2004): (a) To promote 
cell-biomaterial interactions and cell adhesion, (b) To promote ECM deposition, (c) To 
permit sufficient transport of essential gases, nutrients, and regulatory factors for cell 
survival, proliferation, and differentiation and (d) To provoke a minimal degree of 
inflammation or toxicity in vivo.  
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While the “gold standard” for periodontal regeneration and healing is the autograft 
or allograft (Reynolds et al., 2003; O'Brien, 2011), these approaches are integrally limited 
by the amount of available donor tissue and demands a second surgical site, resulting in 
additional trauma to the patient and associated risks such as pain, risks of rejection by the 
patient's immune system, infection, and donor-site morbidity (Chen and Jin, 2010; Hughes 
et al., 2010). Perhaps one of the greatest challenges faced in periodontal regeneration, 
regardless of tissue type, is promoting healing three-dimensionally (Abou Neel et al., 
2014).   
The principle of tissue engineering embodies the creation of a highly porous 
scaffold structure that has the appropriate physical, chemical, and mechanical properties to 
enable cell penetration and tissue reconstruction in three dimensions. In addition to 
defining the 3D geometry for the tissue to be engineered, the scaffold provides the 
microenvironment ‘niche’ for regenerative cells, supporting cell attachment, proliferation, 
differentiation, and neo-tissue formation (Yang et al., 2001; Dhandayuthapani et al., 2011).  
The contribution of scaffolds in periodontal tissue regeneration is crucial as they 
serve as carriers to facilitate delivery of regenerative stem cells and/ or growth factors at a 
local defect site. Moreover, scaffolds should have certain properties conductive for 
regeneration while fulfilling its primary purpose of delivering cells or drugs to the target 
sites, such as follows (Garg et al., 2012): 
1) Biocompatibility: not causing any immune or inflammatory reaction.  
2) Biodegradability at a controllable rate in approximation with the rate of tissue 
regeneration. 
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3) Mechanical properties: maintaining volume (Chen et al., 2009), shape and 
mechanical strength to protect cells.  
4) Architecture: Porous structure to allow cells to be well integrated into the scaffold 
and show tissue-ingrowth. 
5) Physical and chemical structure supporting cell adhesion, proliferation and 
migration. 
2.6.1 Types of scaffolds 
Scaffolds can be broadly classified into synthetic (artificial) and biological (natural) 
(Table 2.1). Biological scaffolds are derived from human and animal tissues, and synthetic 
scaffolds from polymers. Although synthetic scaffolds are available and tailored to the 
needs of the structures to be reconstructed, natural sources of scaffolds are an endless 
substitute for synthetic products and more readily available. Natural scaffolds also have the 
advantage of providing specific cell interactions, biocompatible and are a cheap alternative. 
Among such scaffolds, amniotic membrane holds a unique interest due to its already 
established biological properties such as immunomodulatory action and tissue-like 
characteristics which makes it highly acceptable by the natural host tissues (Akle et al., 
1981; Wang et al., 2006). A deeper understanding of the structure and composition of this 
membrane will help understand its present role and possible future applications in this vast 
arena of tissue engineering. 
  
